143 related articles for article (PubMed ID: 23831568)
1. Alternative CD44 splicing in intestinal stem cells and tumorigenesis.
Guo W; Frenette PS
Oncogene; 2014 Jan; 33(5):537-8. PubMed ID: 23831568
[TBL] [Abstract][Full Text] [Related]
2. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
3. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.
Zeilstra J; Joosten SP; van Andel H; Tolg C; Berns A; Snoek M; van de Wetering M; Spaargaren M; Clevers H; Pals ST
Oncogene; 2014 Jan; 33(5):665-70. PubMed ID: 23318432
[TBL] [Abstract][Full Text] [Related]
4. CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
[TBL] [Abstract][Full Text] [Related]
5. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
Imazeki F; Yokosuka O; Yamaguchi T; Ohto M; Isono K; Omata M
Gastroenterology; 1996 Feb; 110(2):362-8. PubMed ID: 8566581
[TBL] [Abstract][Full Text] [Related]
6. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
[TBL] [Abstract][Full Text] [Related]
7. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer.
Novosad VO; Polikanova IS; Tonevitsky EA; Maltseva DV
Bull Exp Biol Med; 2022 May; 173(1):155-159. PubMed ID: 35618971
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intestinal tumorigenesis in
Wolfe AR; Ernlund A; McGuinness W; Lehmann C; Carl K; Balmaceda N; Neufeld KL
J Cell Sci; 2017 Feb; 130(4):805-813. PubMed ID: 28082422
[TBL] [Abstract][Full Text] [Related]
10. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line.
Asai R; Tsuchiya H; Amisaki M; Makimoto K; Takenaga A; Sakabe T; Hoi S; Koyama S; Shiota G
Cancer Med; 2019 Feb; 8(2):773-782. PubMed ID: 30636370
[TBL] [Abstract][Full Text] [Related]
11. CD44 and the adhesion of neoplastic cells.
Rudzki Z; Jothy S
Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance.
Joosten SPJ; Spaargaren M; Clevers H; Pals ST
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188437. PubMed ID: 32976979
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.
Yang K; Popova NV; Yang WC; Lozonschi I; Tadesse S; Kent S; Bancroft L; Matise I; Cormier RT; Scherer SJ; Edelmann W; Lipkin M; Augenlicht L; Velcich A
Cancer Res; 2008 Sep; 68(18):7313-22. PubMed ID: 18794118
[TBL] [Abstract][Full Text] [Related]
14. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
[TBL] [Abstract][Full Text] [Related]
15. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
16. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
17. The normal structure and function of CD44 and its role in neoplasia.
Sneath RJ; Mangham DC
Mol Pathol; 1998 Aug; 51(4):191-200. PubMed ID: 9893744
[TBL] [Abstract][Full Text] [Related]
18. Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis.
Bruno S; Fabbi M; Tiso M; Santamaria B; Ghiotto F; Saverino D; Tenca C; Zarcone D; Ferrini S; Ciccone E; Grossi CE
Carcinogenesis; 2000 May; 21(5):893-900. PubMed ID: 10783309
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
